Literature DB >> 13864054

A preliminary report on the use of 5-fluorouracil in malignant disease.

C J BAINES, D C LEY.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/therapy; URACIL/related compounds

Mesh:

Substances:

Year:  1962        PMID: 13864054      PMCID: PMC1852066     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Further clinical studies with 5-fluorouracil.

Authors:  F J ANSFIELD; A R CURRERI
Journal:  J Natl Cancer Inst       Date:  1959-03       Impact factor: 13.506

2.  The potentiation of radiation effects with 5-fluorouracil.

Authors:  L V FOYE; F M WILLETT; B HALL; M ROTH
Journal:  Cancer Chemother Rep       Date:  1960-02

3.  Studies on fluorinated pyrimidines. V. Effects on nucleic acid metabolism in vitro.

Authors:  L BOSCH; E HARBERS; C HEIDELBERGER
Journal:  Cancer Res       Date:  1958-04       Impact factor: 12.701

4.  Studies on fluorinated pyrimidines. IV. Effects on nucleic acid metabolism in vivo.

Authors:  P B DANNEBERG; B J MONTAG; C HEIDELBERGER
Journal:  Cancer Res       Date:  1958-04       Impact factor: 12.701

5.  Studies on fluorinated pyrimidines. II. Effects on transplanted tumors.

Authors:  C HEIDELBERGER; L GRIESBACH; B J MONTAG; D MOOREN; O CRUZ; R J SCHNITZER; E GRUNBERG
Journal:  Cancer Res       Date:  1958-04       Impact factor: 12.701

6.  Studies on fluorinated pyrimidines. III. The metabolism of 5-fluorouracil-2-C14 and 5-fluoroorotic-2-C14 acid in vivo.

Authors:  N K CHAUDHURI; B J MONTAG; C HEIDELBERGER
Journal:  Cancer Res       Date:  1958-04       Impact factor: 12.701

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.